Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Centene Corporation (CNC) And Encourages Stockholders to Reach Out

CNC

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Centene Corporation ("Centene" or "the Company") (NYSE:CNC). Investors who purchased Centene securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CNC.

Investigation Details

On July 2, 2025, Seeking Alpha published a report on Centene. According to the report, Centene stock "traded lower on Wednesday after the company withdrew its 2025 earnings guidance, citing a higher-than-anticipated cost trend attributed to its Medicaid enrollees and an unexpected underperformance in its Affordable Care Act plans business." The Company claimed that its "Medicaid business has experienced a step-up in medical cost trend in the same areas previously identified by the Company: behavioral health, home health, and high-cost drugs." Following this news, Centenestock dropped more than 39.5% during intraday trading on the same day.

What's Next?

If you are aware of any facts relating to this investigation or purchased Centene securities, you can assist this investigation by visiting the firm's site: bgandg.com/CNC. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View the original press release on ACCESS Newswire